HOME › DRUGS › FLUTICASONE FUROATE;UMECLIDINIUM;VILANTEROL
ACTIVE SUBSTANCE / INN

FLUTICASONE FUROATE;UMECLIDINIUM;VILANTEROL

Brand name(s): Elebrato Ellipta, Trelegy Ellipta, Temybric Ellipta
EMA LISTED
LAPSED
AUTHORISED
Pulmonary Disease, Chronic Obstructive
ACTIVE SUBSTANCE
Fluticasone Furoate;Umeclidinium;Vilanterol
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Elebrato ElliptaGlaxoSmithKline Trading Services LimitedAuthorised15/11/2017Pulmonary Disease, Chronic Obstructive
Trelegy ElliptaGlaxoSmithKline Trading Services LimitedAuthorised15/11/2017Pulmonary Disease, Chronic Obstructive
Temybric ElliptaGlaxoSmithKline Trading Services LimitedLapsed12/06/2019Pulmonary Disease, Chronic Obstructive

FULL INTELLIGENCE ON FLUTICASONE FUROATE;UMECLIDINIUM;VILANTEROL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →